etoricoxib orion 30 mg
orion corporation - espoo - etorikoksib - tablett, filmdrasjert - 30 mg
etoricoxib orion 60 mg
orion corporation - espoo - etorikoksib - tablett, filmdrasjert - 60 mg
etoricoxib orion 90 mg
orion corporation - espoo - etorikoksib - tablett, filmdrasjert - 90 mg
lyxumia
sanofi winthrop industrie - lixisenatide - diabetes mellitus, type 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.
arcoxia 30 mg
n.v. organon - etorikoksib - tablett, filmdrasjert - 30 mg
arcoxia 60 mg
n.v. organon - etorikoksib - tablett, filmdrasjert - 60 mg
arcoxia 90 mg
n.v. organon - etorikoksib - tablett, filmdrasjert - 90 mg
arcoxia 120 mg
n.v. organon - etorikoksib - tablett, filmdrasjert - 120 mg
etoricoxib sandoz 30 mg
sandoz - københavn - etorikoksib - tablett, filmdrasjert - 30 mg
etoricoxib sandoz 60 mg
sandoz - københavn - etorikoksib - tablett, filmdrasjert - 60 mg